USP evaluates raw materials used in the chemical synthesis of peptides.
Harold Rode
Advertisement
Harold Rode is a consultant at Rode Biologics Consulting.
Articles by Harold Rode
USP evaluates quality attributes for synthetic peptides.
Advertisement
Latest Updated Articles
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material ConsiderationsPublished: April 1st 2014 | Updated:
Control Strategies for Synthetic Therapeutic Peptide APIs— Part I: Analytical ConsiderationPublished: March 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
